FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383483947> ?p ?o ?g. }

• W4383483947 abstract "Abstract Background Although the number of cancer clinical drug trials is increasing rapidly in China, issues concerning informed consent in this research context are understudied. By performing a narrative literature review, we aim to describe the current situation and identify the most salient challenges affecting informed consent in cancer clinical drug trials among adult patients in China since 2000. Methods We searched Web of Science (WOS), PubMed, Scopus, EMBASE, the Cochrane Library databases, China National Knowledge Infrastructure (CNKI), China Biomedical Literature Database on Disc (CBMdisc), Chinese Scientific Journals Fulltext Database (CQVIP), and WANFANG Data to identify relevant publications since 2000. Data were extracted by three reviewers on six items pertaining to study type, theme, and challenges. Results We identified 37 unique manuscripts, from which 19 full texts were obtained and six were included in the review. All six studies were published in Chinese journals, and the publication years of the majority (five out of six) of the studies were 2015 or later. The authors of the six studies were all from clinical departments or ethical review committees at five hospitals in China. All of the included publications were descriptive studies. Publications reported challenges related to the following aspects of informed consent: information disclosure, patient understanding, voluntariness, authorization, and procedural steps. Conclusion Based on our analysis of publications over the past two decades, there are currently frequent challenges related to various aspects of informed consent in cancer clinical drug trials in China. Furthermore, only a limited number of high-quality research studies on informed consent in cancer clinical drug trials in China are available to date. Efforts toward improvement of informed consent practice, in the form of guidelines or further regulations in China, should draw on both experience from other countries and high-quality local evidence." @default.
• W4383483947 created "2023-07-08" @default.
• W4383483947 creator A5001484575 @default.
• W4383483947 creator A5022598993 @default.
• W4383483947 creator A5024063756 @default.
• W4383483947 creator A5032187136 @default.
• W4383483947 creator A5039412958 @default.
• W4383483947 creator A5039898780 @default.
• W4383483947 creator A5069242373 @default.
• W4383483947 creator A5087243103 @default.
• W4383483947 date "2023-07-07" @default.
• W4383483947 modified "2023-10-14" @default.
• W4383483947 title "Informed consent in cancer clinical drug trials in China: a narrative literature review of the past 20 years" @default.
• W4383483947 cites W113054099 @default.
• W4383483947 cites W1916728092 @default.
• W4383483947 cites W1924618820 @default.
• W4383483947 cites W1946700290 @default.
• W4383483947 cites W1964708144 @default.
• W4383483947 cites W1981524388 @default.
• W4383483947 cites W2004393393 @default.
• W4383483947 cites W2029187567 @default.
• W4383483947 cites W2043678288 @default.
• W4383483947 cites W2044115095 @default.
• W4383483947 cites W2047308565 @default.
• W4383483947 cites W2048952536 @default.
• W4383483947 cites W2144628301 @default.
• W4383483947 cites W2152302748 @default.
• W4383483947 cites W2156412191 @default.
• W4383483947 cites W2160733129 @default.
• W4383483947 cites W2272984102 @default.
• W4383483947 cites W2499590469 @default.
• W4383483947 cites W2528898879 @default.
• W4383483947 cites W2556648463 @default.
• W4383483947 cites W2755529452 @default.
• W4383483947 cites W2784472800 @default.
• W4383483947 cites W2795318769 @default.
• W4383483947 cites W2892104271 @default.
• W4383483947 cites W2892749650 @default.
• W4383483947 cites W2895286142 @default.
• W4383483947 cites W2945139022 @default.
• W4383483947 cites W2947173070 @default.
• W4383483947 cites W2967395393 @default.
• W4383483947 cites W2982152932 @default.
• W4383483947 cites W2982337854 @default.
• W4383483947 cites W2995435944 @default.
• W4383483947 cites W3013289853 @default.
• W4383483947 cites W3087244405 @default.
• W4383483947 cites W3131067935 @default.
• W4383483947 cites W3136598208 @default.
• W4383483947 cites W3158400448 @default.
• W4383483947 cites W3187029467 @default.
• W4383483947 cites W3189465882 @default.
• W4383483947 cites W4206693467 @default.
• W4383483947 cites W4214869290 @default.
• W4383483947 cites W4283079763 @default.
• W4383483947 doi "https://doi.org/10.1186/s13063-023-07482-y" @default.
• W4383483947 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37415240" @default.
• W4383483947 hasPublicationYear "2023" @default.
• W4383483947 type Work @default.
• W4383483947 citedByCount "0" @default.
• W4383483947 crossrefType "journal-article" @default.
• W4383483947 hasAuthorship W4383483947A5001484575 @default.
• W4383483947 hasAuthorship W4383483947A5022598993 @default.
• W4383483947 hasAuthorship W4383483947A5024063756 @default.
• W4383483947 hasAuthorship W4383483947A5032187136 @default.
• W4383483947 hasAuthorship W4383483947A5039412958 @default.
• W4383483947 hasAuthorship W4383483947A5039898780 @default.
• W4383483947 hasAuthorship W4383483947A5069242373 @default.
• W4383483947 hasAuthorship W4383483947A5087243103 @default.
• W4383483947 hasBestOaLocation W43834839471 @default.
• W4383483947 hasConcept C118552586 @default.
• W4383483947 hasConcept C142724271 @default.
• W4383483947 hasConcept C151730666 @default.
• W4383483947 hasConcept C153997805 @default.
• W4383483947 hasConcept C17744445 @default.
• W4383483947 hasConcept C189708586 @default.
• W4383483947 hasConcept C191935318 @default.
• W4383483947 hasConcept C199539241 @default.
• W4383483947 hasConcept C204787440 @default.
• W4383483947 hasConcept C2776478404 @default.
• W4383483947 hasConcept C2779343474 @default.
• W4383483947 hasConcept C2779473830 @default.
• W4383483947 hasConcept C512399662 @default.
• W4383483947 hasConcept C535046627 @default.
• W4383483947 hasConcept C68122502 @default.
• W4383483947 hasConcept C71924100 @default.
• W4383483947 hasConcept C86803240 @default.
• W4383483947 hasConceptScore W4383483947C118552586 @default.
• W4383483947 hasConceptScore W4383483947C142724271 @default.
• W4383483947 hasConceptScore W4383483947C151730666 @default.
• W4383483947 hasConceptScore W4383483947C153997805 @default.
• W4383483947 hasConceptScore W4383483947C17744445 @default.
• W4383483947 hasConceptScore W4383483947C189708586 @default.
• W4383483947 hasConceptScore W4383483947C191935318 @default.
• W4383483947 hasConceptScore W4383483947C199539241 @default.
• W4383483947 hasConceptScore W4383483947C204787440 @default.
• W4383483947 hasConceptScore W4383483947C2776478404 @default.
• W4383483947 hasConceptScore W4383483947C2779343474 @default.
• W4383483947 hasConceptScore W4383483947C2779473830 @default.
• W4383483947 hasConceptScore W4383483947C512399662 @default.

• next